Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study

G Le Teuff, A Castaneda-Heredia, C Dufour, T Jaspan, R Calmon, A Devos, K McHugh, P Leblond, D Frappaz, I Aerts, C.M. Zwaan, S Ducassou, P Chastagner, A Verschuur, N Corradini, M Casanova, H Rubie, R Riccardi, MC le Deley, G VassalB Geoerger

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
Original languageUndefined/Unknown
Article numbere28032
JournalPediatric Blood & Cancer
Volume67
Issue number1
DOIs
Publication statusPublished - 2020

Cite this